Related Experiment Video
Updated: Apr 3, 2026
06:16
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
1.1K
Variation in cost-effectiveness in coronary revascularization: a new paradigm for evaluation?
1Virginia Cardiac Surgery Quality Initiative, Value Based Healthcare Solutions, Virginia, USA.
Current Opinion in Cardiology
|September 24, 2015
Summary
Cost-effectiveness analysis is crucial for evaluating healthcare value and standardizing methods. It will increasingly influence provider performance, patient outcomes, and reimbursement, especially for cardiac disease treatments.
Area of Science:
- Health Economics
- Cardiovascular Medicine
- Healthcare Policy
Background:
- Healthcare systems face financial pressures, with national health expenditures growing faster than GDP.
- Cardiac disease, particularly ischemic heart disease, represents a substantial portion of healthcare spending.
- Improving clinical and financial outcomes for revascularization procedures is a priority.
Purpose of the Study:
- To discuss the principles and standardization of cost-effectiveness analysis in healthcare.
- To explore the role of cost-effectiveness in assessing healthcare value and provider performance.
- To examine how cost-effectiveness data can inform reimbursement adjustments.
Main Methods:
- Review of principles and methodology of cost-effectiveness analysis.
- Analysis of recent trials (e.g., SYNTAX, ASCERT) addressing cost-effectiveness in coronary artery disease revascularization.
- Examination of current healthcare spending trends and financial pressures.
Main Results:
- Cost-effectiveness is emerging as a key metric for healthcare provider performance and patient outcomes.
- Challenges in data collection for cost, resource use, and quality of life are being addressed.
- Recent trials demonstrate the feasibility of incorporating cost-effectiveness into outcome measures.
Conclusions:
- Cost-effectiveness analysis is vital for healthcare value assessment and will become a primary measure in disease management payment systems.
- Standardized methodology and data collection are essential for reliable cost-effectiveness evaluations.
- The high prevalence of cardiac disease necessitates the use of cost-effectiveness in adjusting provider payments.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
4.7K
06:32Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
8.6K
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
418
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
418
01:30Acute Coronary Syndrome III: Diagnostic Studies
451
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
451
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.8K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.8K
01:26Coronary Artery Disease IV: Preventive Measures
857
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
857
01:30Coronary Artery Disease I: Introduction
1.6K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
01:26Coronary Artery Disease II: Pathophysiology
989
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
989